Medicare Enrolled
Dr. Gary Freeberg, M.D.
Pulmonary Disease · Great Neck, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Freeberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Freeberg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Freeberg
Dr. Gary Freeberg is a pulmonary disease specialist in Great Neck, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Freeberg performed 3,284 Medicare services across 2,292 unique beneficiaries.
Between the years covered by Open Payments, Dr. Freeberg received a total of $22,293 from 48 pharmaceutical and/or device companies across 1014 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Freeberg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in NY
$22,293 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,284
Medicare services
Top 10% in NY for pulmonary disease
2,292
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~164 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
627 | $111 | $442 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
600 | $74 | $270 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
460 | $111 | $406 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
405 | $25 | $96 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
180 | $121 | $447 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
170 | $201 | $735 |
| Chest X-ray, 1 view An X-ray image of the chest taken from a single angle. This imaging test is used to visualize the structures within the chest cavity. |
145 | $24 | $94 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
133 | $161 | $591 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
123 | $53 | $194 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
123 | $53 | $203 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
100 | $152 | $579 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
62 | $159 | $617 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
60 | $71 | $313 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
29 | $87 | $394 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
27 | $76 | $200 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
27 | $36 | $85 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
13 | $29 | $121 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,293
Total received (2018-2024)
Avg $3,185/year across 7 years
Top 10% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
1,014
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,293 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,043
2023
$2,965
2022
$3,309
2021
$2,843
2020
$1,805
2019
$4,134
2018
$4,193
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$624
AstraZeneca Pharmaceuticals LP
$582
Mylan Specialty L.P.
$246
Boehringer Ingelheim Pharmaceuticals, Inc.
$232
Actelion Pharmaceuticals US, Inc.
$192
Regeneron Healthcare Solutions, Inc.
$161
Electromed, Inc.
$135
Novartis Pharmaceuticals Corporation
$123
Genentech USA, Inc.
$115
Shionogi Inc
$91
Insmed, Inc.
$88
GENZYME CORPORATION
$79
Galvanize Therapeutics, Inc
$75
Mallinckrodt Hospital Products Inc.
$65
Baxter Healthcare
$56
PFIZER INC.
$52
Philips North America LLC
$50
Bayer Healthcare Pharmaceuticals Inc.
$48
Inspire Medical Systems, Inc.
$29
Top 3 companies account for 47.7% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$4,789
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,271
AstraZeneca Pharmaceuticals LP
$2,920
Actelion Pharmaceuticals US, Inc.
$1,551
Genentech USA, Inc.
$1,375
Sunovion Pharmaceuticals Inc.
$897
Regeneron Healthcare Solutions, Inc.
$783
Philips Electronics North America Corporation
$768
Novartis Pharmaceuticals Corporation
$726
Mylan Specialty L.P.
$718
GENZYME CORPORATION
$540
Electromed, Inc.
$519
Insmed, Inc.
$497
Baxter Healthcare
$358
Grifols USA, LLC
$252
Janssen Pharmaceuticals, Inc
$219
PFIZER INC.
$195
Shionogi Inc
$188
Mallinckrodt Hospital Products Inc.
$172
Advanced Respiratory, Inc
$166
Teva Pharmaceuticals USA, Inc.
$157
Olympus America Inc.
$125
Pulmonx Corporation
$125
Amgen Inc.
$94
Chiesi USA, Inc.
$77
Galvanize Therapeutics, Inc
$75
Bayer Healthcare Pharmaceuticals Inc.
$71
ADVANCED RESPIRATORY, INC
$69
Bayer HealthCare Pharmaceuticals Inc.
$59
Philips North America LLC
$50
ZOLL Respicardia, Inc.
$48
Circassia Pharmaceuticals Inc
$45
Merck Sharp & Dohme LLC
$41
Gilead Sciences, Inc.
$32
Merck Sharp & Dohme Corporation
$31
Takeda Pharmaceuticals U.S.A., Inc.
$30
Inspire Medical Systems, Inc.
$29
Mallinckrodt Enterprises LLC
$27
Otsuka America Pharmaceutical, Inc.
$24
Alexion Pharmaceuticals, Inc.
$24
Covis Pharma GmBH
$22
Melinta Therapeutics, LLC
$21
Cumberland Pharmaceuticals, Inc.
$19
E.R. Squibb & Sons, L.L.C.
$19
Phadia US Inc.
$18
La Jolla Pharmaceutical Company
$18
Seqirus USA Inc
$18
Mallinckrodt LLC
$18
Top 3 companies account for 49.3% of all-time payments
Associated products mentioned in payments ›
(1305) Mask · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALIYA SYSTEM · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRIDION · BROVANA · CINQAIR · CLEVIPREX · Caldolor · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · ENTRESTO · Esbriet · FASENRA · Fetroja · Fluad · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - Vest System Model 205 Acute Care · Hillrom - VisiVest Airway Clearance System · INSPIRE · ImmunoCAP · LOKELMA · LONHALA MAGNAIR · Letairis · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PANZYGA · PAXLOVID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QVAR · Respiratoriy Care Undiv · Rezzayo · SAMSCA · SEEBRI · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · SRC Und · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The MetaNeb System · The Vest System 205 Acute Care · The VisiVest Airway Clearance System · Trilogy 100 · ULTOMIRIS · UPTRAVI · UTIBRON · UTIBRON NEOHALER · Utibron · VT Und · Wellcentive Undiv · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for pulmonary disease in NY.
Geographic Context
Pulmonary diseases within 10 mi
628
Per 100K population
45.2
County median income
$143,408
Nearest hospital
NORTH SHORE UNIVERSITY HOSPITAL
2.4 mi
2.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Freeberg is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NY), with low-engagement industry engagement in the top 10% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Freeberg experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Freeberg performed 627 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Freeberg receive payments from pharmaceutical companies?
Yes. Dr. Freeberg received a total of $22,293 from 48 companies across 1,014 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Freeberg's costs compare to other pulmonary diseases in Great Neck?
Dr. Freeberg's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Freeberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Great Neck
Browse pulmonary diseases in Great Neck ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology